title: Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma.
authors.forename: Thomas
authors.initials: T
authors.lastname: Asklund
authors.forename: Roger
authors.initials: R
authors.lastname: Henriksson
authors.forename: Jan
authors.initials: J
authors.lastname: Axelsson
authors.forename: Åsa
authors.initials: Å
authors.lastname: Bergström
authors.forename: Maria
authors.initials: M
authors.lastname: Kasper
authors.forename: Margareta
authors.initials: M
authors.lastname: Ögren
authors.forename: Rune
authors.initials: R
authors.lastname: Toftgård
authors.forename: Katrine Åhlström
authors.initials: KÅ
authors.lastname: Riklund
mesh_terms: D000328:Adult; D000813:Anilides / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D002528:Cerebellar Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D011725:Pyridines / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D012074:Remission Induction / Q000379:methods; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines